Navigation Links
Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action
Date:1/8/2009

BETHESDA, Md., Jan. 8 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; AIM: NWBS and NWBT) (the "Company" or "NWBT") announced today settlement of a putative securities class action lawsuit, In re Northwest Biotherapeutics, Inc. Securities Litigation, No. C-07-1254-RAJ. The Company has agreed to pay in settlement US$1 million, which is to be funded out of insurance proceeds. The settlement must be approved by the Court. Additional details about the settlement can be found in the formal settlement documents, which are available from the United States District Court for the Western District of Washington. The case alleged that the Company misrepresented certain facts that resulted in the artificial inflation of the price of Northwest Biotherapeutics publicly-traded common stock between April 17, 2007 and July 18, 2007. The Company disputes the allegations of the lawsuit, and denies that there was any such misrepresentation or that the shares of Northwest Biotherapeutics common stock were artificially inflated. Nevertheless the Company is settling the lawsuit to avoid potentially expensive and protracted litigation.

The Company also announced today that the formal investigation by the SEC into these matters has been closed without any action taken.

Dr. Alton Boynton, CEO of Northwest Biotherapeutics, stated that, "We are pleased to have settled this litigation, and we believe this outcome is in the best interests of the Company and its shareholders. Of course, we are also pleased to have the SEC investigation behind us."

The Company will need to raise additional capital to fund its clinical trials and other operating activities and to repay indebtedness in due course. Shareholders should be aware that if the Company's capital raising efforts are unsuccessful, this will have a material adverse effect on the Company's financial position and operations.
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
2. Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
3. Cell Therapeutics, Inc. (CTI) to Present at 7th Annual WBBA Invest Northwest Conference
4. Cell Therapeutics, Inc. (CTI) Invest Northwest Presentation to be Webcast
5. Northwest Secures US$4.0 Million in Debt Financing
6. Nikon Instruments Opens New Imaging Center at Northwestern University
7. Northwestern chemist investigates lost reds in Homer painting
8. Northwest Biotherapeutics to Present at Next Generation Vaccine Conference
9. Northwestern chemists take gold, mass-produce Beijing Olympic logo
10. Northwest Secures US$1.0 Million Debt Financing
11. Northwest Secures US$1.65 Million Debt Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... and VANCOUVER , March 31, 2015 ... EPI) announced today that it has filed with the ... Investigation New Drug ("IND") application related to the Company,s ... Approval of the IND application is required in order ... the US.  The IND application is ...
(Date:3/31/2015)... , March 31, 2015  Bayer HealthCare (Bayer) ... of Massachusetts Institute of Technology (MIT) and Harvard ... The goal of this new part of the ... to help create new cardiovascular therapies. ... the Broad Institute to the area of cardiovascular ...
(Date:3/31/2015)... 31, 2015 This June 13th, a ... top U.S and International Medical Schools will come together ... on the application of stem cell therapy in treatments ... organized and funded by the Ocular Research Symposia ... been convening intimate meetings of top experts in the ...
(Date:3/30/2015)... PMG Research, Benchmark Research, and Miami ... of VaxCorps, a network of highly experienced, geographically ... of vaccine trials in healthy adult, elderly, and ... conducted over 500 phase I-III vaccine clinical trials, ... as well as a vast array of other ...
Breaking Biology Technology:ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 2ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 3ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 4Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 2Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease 3Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2
... Readies R & D facilities for Ap3ana, CTI,s ... Cell Therapeutics, Inc. (CTI),(Nasdaq: CTIC ) announced ... President and COO of a Tyr Pharma and ... the Novartis Research,Foundation, has been named President of ...
... BioPharma,Corp. (TSX; FSE: HBP) today announced that it has ... 6,800,000 units at $1.68 per,unit, for gross proceeds totaling ... and one-half of one common share,purchase warrant, with each ... subject to adjustment, one common share at a price,of ...
... Investors, WILMINGTON, Del., Oct. 2 Speaking ... General Manager John Ranieri,said the company,s plans to ... on track and making significant technical progress toward ... feedstocks,economically into biofuels., "Biobutanol and cellulosic ethanol ...
Cached Biology Technology:Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 2Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 3Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe 4Helix Biopharma Closes $11.4 Million Private Placement 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 2DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels 3
(Date:3/4/2015)... 04, 2015 Research and Markets ... the "Global Biometrics Market Forecast and Opportunities, ... The market for biometric authentication systems is projected ... till 2020 The driving forces for ... needs, government projects and constant development in technology. ...
(Date:3/2/2015)... SAN JOSE, Calif. , March 2, 2015 ... ), the leading developer of human interface solutions, ... ID technology that is designed to enable rapid ... Synaptics Natural ID™ module for gaming is a ... and ODMs the ability to quickly integrate fingerprint ...
(Date:3/2/2015)... Lithuania , March 2, 2015   Neurotechnology ... technologies, today introduced the SentiGaze Software Development Kit ... to create applications that use off-the-shelf webcams to track ... user gazes at a monitor. Heatmaps can be used ... the effectiveness of online advertising. The SDK can also ...
Breaking Biology News(10 mins):Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3
... obesity increasing, school administrators and public health officials are ... a study published in the November/December 2008 issue of ... researchers found that reduction or elimination of SSB from ... adolescents. Working with four schools in Maine ...
... to be averted, atmospheric carbon dioxide (CO2) must be reduced below ... in Open Atmospheric Science Journal by a ... and France. The authors, who include two Yale ... which civilization developed, an optimum CO2 level would be less than ...
... Ph.D., of the New York City Department of Health and ... be one of our body,s main protections against damage from ... of Low Radiation , Hayes explains that calcitriol, the active ... and could be used as a safe protective agent before ...
Cached Biology News:Revised theory suggests carbon dioxide levels already in danger zone 2Could vitamin D save us from radiation? 2